Survival outcomes in EGFR mutation-positive lung cancer patients treated with gefitinib until or beyond progression
FV Moiseyenko, VM Moiseyenko… - Oncology Research …, 2016 - karger.com
Background: Discontinuation of gefitinib treatment is often accompanied by a disease flare.
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression
FV Moiseyenko, VM Moiseyenko… - Oncology research …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Discontinuation of gefitinib treatment is often accompanied by a disease flare.
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
[引用][C] Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression
FV Moiseyenko, VM Moiseyenko… - Oncology Research …, 2016 - elibrary.ru
MOISEYENKO FV 1, 2, 3, MOISEYENKO VM 1, CHUBENKO VA 1, VOLKOV NM 1,
KOZYREVA KS 1, KRAMCHANINOV MM 1, ZHURAVLEV AS 1, SHELEKHOVA KV 1, 2 …
KOZYREVA KS 1, KRAMCHANINOV MM 1, ZHURAVLEV AS 1, SHELEKHOVA KV 1, 2 …
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression
FV Moiseyenko, VM Moiseyenko… - Oncology Research …, 2016 - karger.com
Background: Discontinuation of gefitinib treatment is often accompanied by a disease flare.
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
FV Moiseyenko, VM Moiseyenko… - Oncology Research …, 2016 - europepmc.org
Background Discontinuation of gefitinib treatment is often accompanied by a disease flare.
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
FV Moiseyenko, VM Moiseyenko… - Oncology Research …, 2016 - search.ebscohost.com
Background: Discontinuation of gefitinib treatment is often accompanied by a disease flare.
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …
Some studies have demonstrated a benefit of the use of epidermal growth factor receptor …